|Bid||39.44 x 800|
|Ask||39.46 x 1100|
|Day's range||38.70 - 40.95|
|52-week range||38.70 - 64.02|
|Beta (5Y monthly)||1.16|
|PE ratio (TTM)||786.62|
|Forward dividend & yield||1.80 (4.14%)|
|Ex-dividend date||30 Sept 2022|
|1y target est||N/A|
Ventas got hit hard during the early days of the pandemic. Things are better, but dividend investors are still waiting for a real turnaround.
Rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet will aid Ventas (VTR). Yet, stiff competition and higher interest rates are woes.
Ventas got hit hard by the coronavirus pandemic, but now that it's turning around the business upside could be material.